Gene: KCNK3
Official Full Name: potassium two pore domain channel subfamily K member 3provided by HGNC
Gene Summary: This gene encodes a member of the superfamily of potassium channel proteins that contain two pore-forming P domains. The encoded protein is an outwardly rectifying channel that is sensitive to changes in extracellular pH and is inhibited by extracellular acidification. Also referred to as an acid-sensitive potassium channel, it is activated by the anesthetics halothane and isoflurane. Although three transcripts are detected in northern blots, there is currently no sequence available to confirm transcript variants for this gene. [provided by RefSeq, Aug 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36957 | KCNK3 Knockout cell line (HeLa) | Human | KCNK3 | 1:3~1:6 | Negative | Online Inquiry |
KO36958 | KCNK3 Knockout cell line (A549) | Human | KCNK3 | 1:3~1:4 | Negative | Online Inquiry |
KCNK3 Gene Knockout Cell Lines are specialized cellular models engineered to lack the KCNK3 gene, which encodes a potassium ion channel critical for regulating neuronal excitability and vascular function. These cell lines are generated through advanced CRISPR-Cas9 gene editing technology, ensuring precise disruption of the gene, leading to the study of its physiological and pathological roles in various cellular contexts. The knockout of KCNK3 provides a unique opportunity to investigate the channel's contributions to processes such as neurotransmitter release, cardiac rhythm regulation, and endothelial function.
The primary function of KCNK3 potassium channels includes the modulation of resting membrane potential and cellular excitability. By utilizing these knockout cell lines, researchers can observe altered responses to electrical stimuli and changes in ionic homeostasis, allowing for an in-depth understanding of the KCNK3 gene's implications in conditions such as pulmonary hypertension, atrial fibrillation, and neurodegenerative diseases. This is critical for developing targeted therapies and innovative drug discoveries.
Compared to traditional cell lines that express KCNK3, our knockout lines offer a clear delineation of the gene's impact, thus providing more accurate data for studies related to ion channel function and pathophysiology. Furthermore, the precision with which these cells are created minimizes off-target effects, enhancing the reliability of experimental outcomes.
The value of KCNK3 Gene Knockout Cell Lines lies in their ability to serve as an essential tool for both academic and pharmaceutical research settings. They empower users to explore hypotheses surrounding potassium channel functionality with higher specificity and confidence. Our commitment to producing high-quality, precisely engineered biological products stems from years of expertise in molecular genetics and cell biology, ensuring that researchers and clinicians receive the advanced tools necessary for impactful discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.